| Literature DB >> 31826088 |
Sergio Renato Pais-Costa1,2,3, Guilherme Costa Crispim de Sousa2,3, Sergio Luiz Melo Araujo2,3, Olímpia Alves Teixeira Lima1,2,3, Sandro José Martins3, Orlando J Torres4.
Abstract
BACKGROUND: Laparoscopic distal pancreatectomy (LDP) is the preferred approach for resection of tumors in the distal pancreas because of its many advantages over the open approach. AIM: To analyse and compare short and long-term outcomes from LDP performed through two different techniques: with splenectomy vs. spleen preservation and splenic vessel preservation.Entities:
Mesh:
Year: 2019 PMID: 31826088 PMCID: PMC6902889 DOI: 10.1590/0102-672020190001e1461
Source DB: PubMed Journal: Arq Bras Cir Dig ISSN: 0102-6720
FIGURE 1Final aspect of the procedure: A) LDPSPPSV (stump of pancreas was stapled and splenic vessels were preserved); B) LDPS (stump of pancreas was stapled and splenic vessels were ligated with Hemolok clips)
FIGURE 2Late results: A) LDPS with position of the portals and incision of Pfannenstiel; B) LDPSPPSV with position of the portals and enlargement of the portal of 12 mm in the right flank for removal of the surgical specimen
FIGURE 3Survival in relation to the type of lesion operated
Epidemiological characteristics and early results
| Groups | 1 (Splenectomy) | 2 (Spleen preservation) | p |
| n | 32 | 26 | 0.87 |
| Age* | 51.0 years (20 - 78) | 47.9 years (21 - 75) | 0.43 |
| Gender | |||
| Female | 20 (62.5 %) | 17 (65.8 %) | 0.85 |
| Male | 12 (37.5%) | 12 (34.6 %) | |
| Comorbidity | 8 (25 %) | 6 (23 %) | 0.77 |
| ASA II | 8 (25 %) | 6 (23 %) | 0.77 |
| BMI* | 28.5 kg/m² (18.3 - 38.3) | 25.6 kg/m² (18 - 38.8) | 0.06 |
| Lesion size* | 4.9 cm (2 - 12) | 4.3 cm (1.8 - 7.5) | 0.2 |
| Duration of operation* | 179.9 minutes (70 - 360) | 144.1 minutes (90 - 200) | 0.04* |
| Bleeding* | 244.11 ml (0 - 1000) | 119.2 ml (50 - 600) | 0.03* |
| Resected lymph nodes* | 7.07 (3-12) | 2.72 (1-6) | 0.000* |
| Weight of surgical specimen** | 162.3 gr (85.1-565.3) | 161.5 gr (81,3-358.5) | 0.76 |
| Duration of hospitalization* | 5.4 days (2 - 13) | 4.8 days (2 - 14) | 0.43 |
| Conversion | 2 (6.2 %) | 1 (3.8% ) | 0.59 |
| Postoperative complications | 7 ( 22 %) | 6 (23 %) | 0,93 |
| Mortality | 1 (3.4%) | 0 | 0.31 |
| Positive margins | 2 (6.8%) | 1 (3,8%) | 0.66 |
| Pancreatic fistula (grades B and C) | 4 (12.5%) | 3 (10.3%) | 0.76 |
*=Variables described in means, *”*=spleen excluded
Etiology of pancreatic lesions
| Histological time | Group 1 | Group 2 |
| Adenocarcinoma | 5 (17.2%) | 0 |
| Mucinous cystadenocarcinoma | 1 (3.4%) | 0 |
| Mucinous cystadenoma | 9 (31%) | 7 (24.1%) |
| Serous cystadenoma | 3 (10.3%) | 7 (24.1%) |
| IPMN | 3 (10.3%) | 7 (24.1%) |
| Neuroendocrine tumor | 6 (20.6%) | 5 (17.2%) |
| PSCT (Frantz) | 2 (6.8%) | 2 (6.8%) |
| Accessory spleen | 0 | 1 (3.4%) |
IPMN=intraductal papillary mucinous neoplasia; PSCT=pseudopapillary solid cystic tumor
Late results
| Groups | 1 (Splenectomy) | 2 (Spleen preservation) | p |
| n | 32 | 26 | |
| Late complications | 5 (15.6%) | 5 (19.2%) | 0.93 |
| Follow-up | 43.5 months (5 - 96) | 31.7 months (12 - 72) | 0.35 |
| Recurrence | 6 (20.68%) | 0 | 0.01* |